Sep 05, 2023
Keros Therapeutics to Present at Upcoming Healthcare Conferences
Aug 07, 2023
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
Jul 27, 2023
Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
Jul 24, 2023
Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
Jun 12, 2023
Keros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference
Jun 09, 2023
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association
Jun 07, 2023
Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
May 22, 2023
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
May 11, 2023
Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association
May 04, 2023
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
Displaying 1 - 10 of 14